ALAN Maladies Rares Luxembourg asbl, the national rare disease alliance of Luxemburg is pleased with the importance given to health and health care by the EU Commission which is illustrated by the unprecedented budget of the current EU4Health Program. Furthermore, we welcome the broad scope of objectives which covers multiple areas which are key for the rare disease community.
ALAN Maladies Rares Luxembourg
NGO · Luxembourg · EU Transparency Register 961973546240-11
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 784 non-governmental organisations on this site, they rank #453 by legislative files engaged — a count of participation, not a measure of influence.
Declares membership of
- EURORDIS
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).
- Register category
- Non-governmental organisations
- Registered as
- ALAN asbl-Maladies Rares Luxembourg (ALAN)
- Head office
- Kockelscheuer, Luxembourg
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track ALAN in PolicySpeak: request access →
Work at ALAN Maladies Rares Luxembourg? so we know who speaks for it.
Their record over time
ALAN Maladies Rares Luxembourg filed 1 position on 8 Jan 2024, across 1 of the 326 legislative files tracked here.
What they argued
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Is this your organization?
Everything on this page comes from ALAN Maladies Rares Luxembourg’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.